Description
July 28, 2025:
Rising cervical cancer rates and a new at-home screening test for cervical cancer
Register for CAP25 – The Pathologists' Meeting
Too few phlebotomists—is Aletta the answer?
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
A media briefing on the role of clinical labs in fighting infectious disease, and a promising new at-home screening test for cervical cancer. This and more coming up next on Path News Network. Hello and welcome to Path News Network Daily Edition, powered by the College of American Pathologists. I'm Nancy Johnson. It's Monday, July 28th. Here are the latest headlines. As infectious disease threats grow, clinical labs remain the nation's first line of defense. Tomorrow in Chicago, experts from the CAP, including President-elect Dr. Qihui "Jim" Zhai, will host a press briefing at the Association for Diagnostics and Laboratory Medicine Conference. The focus? Lab readiness for vector and airborne diseases. CAP leaders will also preview new proficiency testing and surveys for 2026. In other laboratory medicine news, cervical cancer rates are on the rise, particularly in women ages 30 to 44. CAP Governor Dr. Ritu Nayar joined AMA Update to highlight how new screening tools could help reverse this trend. The FDA recently approved an at-home dry swab self-collection device that may improve early detection. To watch the full video interview and learn more about screening and the importance of HPV vaccination, check out the show notes. New CAP guidelines are coming to standardize amyloidosis workups, and you can get a first look at CAP25 in Orlando. With promising treatments now available, consistent diagnosis is more important than ever. Join CAP faculty for a CME accredited session covering evidence-based recommendations, case studies, and practical tools for accurate amyloid detection and reporting. Go to the link in the show notes to register using code CME25200 to receive $200 off an all-access pass. And finally, phlebotomists are in short supply. So could a robot be the answer? In this month's edition of CAP Today, Northwestern Memorial Hospital shares how it's testing the Vitestro Aletta, an autonomous robotic phlebotomy device that's already performed over 6,000 blood draws in Europe. Named after the first female Dutch physician, the Aletta is now being studied at Northwestern Mayo Clinic, as well as Baylor, Scott and White, as it moves toward U.S. approval. Go to the article in the show notes to find out how this robot could be a game changer for outpatient blood collection. That's all for today's edition of Path News Network. Be sure to watch your email inbox for more news like this in the CAP's advocacy newsletter every Tuesday and our weekly edition newsletter on Thursdays. Listen here again tomorrow at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great day.
Description
July 28, 2025:
Rising cervical cancer rates and a new at-home screening test for cervical cancer
Register for CAP25 – The Pathologists' Meeting
Too few phlebotomists—is Aletta the answer?
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
A media briefing on the role of clinical labs in fighting infectious disease, and a promising new at-home screening test for cervical cancer. This and more coming up next on Path News Network. Hello and welcome to Path News Network Daily Edition, powered by the College of American Pathologists. I'm Nancy Johnson. It's Monday, July 28th. Here are the latest headlines. As infectious disease threats grow, clinical labs remain the nation's first line of defense. Tomorrow in Chicago, experts from the CAP, including President-elect Dr. Qihui "Jim" Zhai, will host a press briefing at the Association for Diagnostics and Laboratory Medicine Conference. The focus? Lab readiness for vector and airborne diseases. CAP leaders will also preview new proficiency testing and surveys for 2026. In other laboratory medicine news, cervical cancer rates are on the rise, particularly in women ages 30 to 44. CAP Governor Dr. Ritu Nayar joined AMA Update to highlight how new screening tools could help reverse this trend. The FDA recently approved an at-home dry swab self-collection device that may improve early detection. To watch the full video interview and learn more about screening and the importance of HPV vaccination, check out the show notes. New CAP guidelines are coming to standardize amyloidosis workups, and you can get a first look at CAP25 in Orlando. With promising treatments now available, consistent diagnosis is more important than ever. Join CAP faculty for a CME accredited session covering evidence-based recommendations, case studies, and practical tools for accurate amyloid detection and reporting. Go to the link in the show notes to register using code CME25200 to receive $200 off an all-access pass. And finally, phlebotomists are in short supply. So could a robot be the answer? In this month's edition of CAP Today, Northwestern Memorial Hospital shares how it's testing the Vitestro Aletta, an autonomous robotic phlebotomy device that's already performed over 6,000 blood draws in Europe. Named after the first female Dutch physician, the Aletta is now being studied at Northwestern Mayo Clinic, as well as Baylor, Scott and White, as it moves toward U.S. approval. Go to the article in the show notes to find out how this robot could be a game changer for outpatient blood collection. That's all for today's edition of Path News Network. Be sure to watch your email inbox for more news like this in the CAP's advocacy newsletter every Tuesday and our weekly edition newsletter on Thursdays. Listen here again tomorrow at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great day.
Share
Embed
You may also like
Description
July 28, 2025:
Rising cervical cancer rates and a new at-home screening test for cervical cancer
Register for CAP25 – The Pathologists' Meeting
Too few phlebotomists—is Aletta the answer?
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
A media briefing on the role of clinical labs in fighting infectious disease, and a promising new at-home screening test for cervical cancer. This and more coming up next on Path News Network. Hello and welcome to Path News Network Daily Edition, powered by the College of American Pathologists. I'm Nancy Johnson. It's Monday, July 28th. Here are the latest headlines. As infectious disease threats grow, clinical labs remain the nation's first line of defense. Tomorrow in Chicago, experts from the CAP, including President-elect Dr. Qihui "Jim" Zhai, will host a press briefing at the Association for Diagnostics and Laboratory Medicine Conference. The focus? Lab readiness for vector and airborne diseases. CAP leaders will also preview new proficiency testing and surveys for 2026. In other laboratory medicine news, cervical cancer rates are on the rise, particularly in women ages 30 to 44. CAP Governor Dr. Ritu Nayar joined AMA Update to highlight how new screening tools could help reverse this trend. The FDA recently approved an at-home dry swab self-collection device that may improve early detection. To watch the full video interview and learn more about screening and the importance of HPV vaccination, check out the show notes. New CAP guidelines are coming to standardize amyloidosis workups, and you can get a first look at CAP25 in Orlando. With promising treatments now available, consistent diagnosis is more important than ever. Join CAP faculty for a CME accredited session covering evidence-based recommendations, case studies, and practical tools for accurate amyloid detection and reporting. Go to the link in the show notes to register using code CME25200 to receive $200 off an all-access pass. And finally, phlebotomists are in short supply. So could a robot be the answer? In this month's edition of CAP Today, Northwestern Memorial Hospital shares how it's testing the Vitestro Aletta, an autonomous robotic phlebotomy device that's already performed over 6,000 blood draws in Europe. Named after the first female Dutch physician, the Aletta is now being studied at Northwestern Mayo Clinic, as well as Baylor, Scott and White, as it moves toward U.S. approval. Go to the article in the show notes to find out how this robot could be a game changer for outpatient blood collection. That's all for today's edition of Path News Network. Be sure to watch your email inbox for more news like this in the CAP's advocacy newsletter every Tuesday and our weekly edition newsletter on Thursdays. Listen here again tomorrow at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great day.
Description
July 28, 2025:
Rising cervical cancer rates and a new at-home screening test for cervical cancer
Register for CAP25 – The Pathologists' Meeting
Too few phlebotomists—is Aletta the answer?
Hosted on Ausha. See ausha.co/privacy-policy for more information.
Transcription
A media briefing on the role of clinical labs in fighting infectious disease, and a promising new at-home screening test for cervical cancer. This and more coming up next on Path News Network. Hello and welcome to Path News Network Daily Edition, powered by the College of American Pathologists. I'm Nancy Johnson. It's Monday, July 28th. Here are the latest headlines. As infectious disease threats grow, clinical labs remain the nation's first line of defense. Tomorrow in Chicago, experts from the CAP, including President-elect Dr. Qihui "Jim" Zhai, will host a press briefing at the Association for Diagnostics and Laboratory Medicine Conference. The focus? Lab readiness for vector and airborne diseases. CAP leaders will also preview new proficiency testing and surveys for 2026. In other laboratory medicine news, cervical cancer rates are on the rise, particularly in women ages 30 to 44. CAP Governor Dr. Ritu Nayar joined AMA Update to highlight how new screening tools could help reverse this trend. The FDA recently approved an at-home dry swab self-collection device that may improve early detection. To watch the full video interview and learn more about screening and the importance of HPV vaccination, check out the show notes. New CAP guidelines are coming to standardize amyloidosis workups, and you can get a first look at CAP25 in Orlando. With promising treatments now available, consistent diagnosis is more important than ever. Join CAP faculty for a CME accredited session covering evidence-based recommendations, case studies, and practical tools for accurate amyloid detection and reporting. Go to the link in the show notes to register using code CME25200 to receive $200 off an all-access pass. And finally, phlebotomists are in short supply. So could a robot be the answer? In this month's edition of CAP Today, Northwestern Memorial Hospital shares how it's testing the Vitestro Aletta, an autonomous robotic phlebotomy device that's already performed over 6,000 blood draws in Europe. Named after the first female Dutch physician, the Aletta is now being studied at Northwestern Mayo Clinic, as well as Baylor, Scott and White, as it moves toward U.S. approval. Go to the article in the show notes to find out how this robot could be a game changer for outpatient blood collection. That's all for today's edition of Path News Network. Be sure to watch your email inbox for more news like this in the CAP's advocacy newsletter every Tuesday and our weekly edition newsletter on Thursdays. Listen here again tomorrow at 5 a.m. Eastern for another episode of The Daily Edition. I'm Nancy Johnson. Have a great day.
Share
Embed
You may also like
